PRESS RELEASE published on 06/30/2025 at 07:43, 1 year 4 months ago EQS-Adhoc: clearvise AG: Chief Executive Officer considers stepping down from the Management Board at the end of her current term of office on 28 February 2026 Clearvise AG's CEO is considering stepping down from the Management Board at the end of her current term on 28 February 2026, citing personal reasons Management Board CEO Clearvise AG 2026 Step Down
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Nouveaux marchés des drones autonomes : première commande d'une flotte de drones de surface DriX pour des missions de surveillance maritime Exail Technologies remporte une commande historique de drones de surface pour une application navale ISR, renforçant la sécurité maritime et les capacités opérationnelles des forces navales Sécurité Maritime Exail Technologies Commande Historique Drones De Surface Application Navale ISR
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago New markets for autonomous drones: first order for a fleet of DriX surface drones for maritime surveillance missions Exail Technologies secures major contract with European navy for DriX surface drones to enhance maritime surveillance capabilities and intelligence missions Exail Technologies Autonomous Systems DriX Surface Drones Naval Application Maritime Surveillance Missions
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Le Groupe Bastide et le Groupe Sapio ont signé un accord portant sur la cession de Baywater Healthcare Cession de Baywater Healthcare UK Limited (filiale de Bastide le Confort Medical) au Groupe Sapio pour désendettement et croissance. Opération attendue au T3 2025 Croissance Cession Désendettement Baywater Healthcare Groupe Sapio
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Bastide Groupe Sells Baywater Healthcare To Sapio Group Groupe Bastide sells Baywater Healthcare UK Ltd to Sapio Group, aiming to reduce debt through strategic transactions. Sapio continues its European healthcare expansion Healthcare Sector Strategic Transactions Groupe Bastide Baywater Healthcare Sapio Group
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Lhyfe devient le 1er acteur français à obtenir la certification européenne RFNBO - la plus haute exigence écologique de la filière - pour sa production d'hydrogène vert Lhyfe livre les premiers lots d'hydrogène certifié RFNBO en France, élevant le standard écologique de la filière. Expansion prévue en Allemagne Certification Décarbonation Hydrogène Lhyfe RFNBO
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Lhyfe becomes first French player to obtain European RFNBO certification - the renewable hydrogen industry's highest ecological standard - for its production Lhyfe delivers first RFNBO-certified hydrogen in France, achieving highest ecological standards for renewable hydrogen industry. Bouin site receives certification and others soon to follow Renewable Energy Certification Hydrogen Lhyfe RFNBO
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Press release: Availability of the Q2 2025 Aide mémoire Sanofi releases Q2 2025 Aide mémoire for financial modelling, to be published on July 31, 2025. Company details its commitment to innovation and impact in healthcare Innovation Sanofi Aide Mémoire Financial Modelling Q2 2025
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial Nicox announces completion of Denali Phase 3 trial for NCX 470 eye drop, expecting results mid-August to mid-September 2025. NDA submission in the U.S. targeted for H1 2026 Phase 3 Trial Ophthalmology Nicox NCX 470 NDA Submission
PRESS RELEASE published on 06/30/2025 at 07:30, 1 year 4 months ago Nicox annonce que le dernier patient a terminé l’essai clinique de Phase 3 Denali sur NCX 470 Nicox annonce la fin de l'essai clinique de Phase 3 Denali sur NCX 470. Premiers résultats attendus entre mi-août et mi-septembre 2025. Autorisation de mise sur le marché aux Etats-Unis prévue pour le premier semestre 2026 Essai Clinique Pharmaceutique Nicox NCX 470 Glaucome
Published on 11/14/2026 at 12:56, 13 hours 54 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day 1 hour ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 2 hours ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 2 hours ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 2 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 3 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 4 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 7 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 7 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 15 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 15 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 18 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 3 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)